MedPage Today) — SAN FRANCISCO — Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy (MDT) in addition to systemic treatment, a meta-analysis of recent studies showed…
Metastasis-Directed Therapy for Prostate Cancer a Clear Winner in Meta-Analysis

Leave a Comment Leave a Comment